CD62L (L-selectin) shedding for assessment of functional blockade of TNF alpha in anti-TNF treated IBD patients: clinical feasibility and perspectives
Data(s) |
2014
|
---|---|
Formato |
application/pdf |
Identificador |
http://boris.unibe.ch/67475/1/Seiten_a45_a46_aus%20A1.full.pdf Juillerat, Pascal; Andrew, Peter Michael; Macpherson, James; Slack, Emma; Cahenzli, Julia; Seibold, F.; McCoy, Kathleen; Macpherson, Andrew (2014). CD62L (L-selectin) shedding for assessment of functional blockade of TNF alpha in anti-TNF treated IBD patients: clinical feasibility and perspectives. United European Gastroenterology Journal, 2(1suppl), A45-A46. Sage doi:10.7892/boris.67475 urn:issn:2050-6406 |
Idioma(s) |
eng |
Publicador |
Sage |
Relação |
http://boris.unibe.ch/67475/ |
Direitos |
info:eu-repo/semantics/openAccess |
Fonte |
Juillerat, Pascal; Andrew, Peter Michael; Macpherson, James; Slack, Emma; Cahenzli, Julia; Seibold, F.; McCoy, Kathleen; Macpherson, Andrew (2014). CD62L (L-selectin) shedding for assessment of functional blockade of TNF alpha in anti-TNF treated IBD patients: clinical feasibility and perspectives. United European Gastroenterology Journal, 2(1suppl), A45-A46. Sage |
Palavras-Chave | #610 Medicine & health |
Tipo |
info:eu-repo/semantics/conferenceObject info:eu-repo/semantics/publishedVersion PeerReviewed |